Literature DB >> 22684577

Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study.

Eric L Wallace1, Susan S Smyth.   

Abstract

Cardiac complications following stroke or acute cerebrovascular accidents (CVA) are common; however, many of these complications are asymptomatic and do not cause adverse cardiac effects. Symptomatic events (such as acute myocardial infarction after CVA) rarely occur and are often the result of an underlying cardiac embolic source, such as a left ventricular thrombus. We report a case of spontaneous coronary thrombosis following thrombolytic therapy for acute CVA, and discuss the implication that an underlying systemic pro-thrombotic state may predispose individuals to thrombosis in disparate vascular beds.

Entities:  

Mesh:

Year:  2012        PMID: 22684577      PMCID: PMC3697839          DOI: 10.1007/s11239-012-0754-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  22 in total

1.  Fatal embolic myocardial infarction after systemic thrombolysis for stroke.

Authors:  Wassilios Meissner; Thomas Lempert; Sabine Saeuberlich-Knigge; Wolfgang Bocksch; Ulrich-Frank Pape
Journal:  Cerebrovasc Dis       Date:  2006-06-08       Impact factor: 2.762

Review 2.  Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis.

Authors:  Emmanuel Touzé; Olivier Varenne; Gilles Chatellier; Séverine Peyrard; Peter M Rothwell; Jean-Louis Mas
Journal:  Stroke       Date:  2005-10-27       Impact factor: 7.914

3.  Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis.

Authors:  Raymond C S Seet; Yi Zhang; S Arthur Moore; Eelco F Wijdicks; Alejandro A Rabinstein
Journal:  Stroke       Date:  2011-06-09       Impact factor: 7.914

4.  Individual propensity for arterial thrombosis.

Authors:  W E Wysokinski; R D McBane; W G Owen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

5.  Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.

Authors:  David Tanne; Richard F Macko; Yan Lin; Barbara C Tilley; Steven R Levine
Journal:  Stroke       Date:  2006-06-08       Impact factor: 7.914

6.  Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events.

Authors:  S Sen; S Laowatana; J Lima; S M Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

7.  Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention.

Authors:  Pierre Amarenco; Philippe Gabriel Steg
Journal:  Eur Heart J       Date:  2008-06-03       Impact factor: 29.983

8.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690

9.  Myocardial infarction coincident with cerebrovascular accidents in the elderly.

Authors:  P L Chin; J Kaminski; M Rout
Journal:  Age Ageing       Date:  1977-02       Impact factor: 10.668

10.  Myocardial infarction following t-PA for acute stroke.

Authors:  M Mehdiratta; C Murphy; A Al-Harthi; P A Teal
Journal:  Can J Neurol Sci       Date:  2007-11       Impact factor: 2.104

View more
  4 in total

1.  Stroke thrombolysis complicated by ST elevation myocardial infarction (STEMI).

Authors:  Mark Flower; James Harvey; Jonathan Hunter
Journal:  BMJ Case Rep       Date:  2018-03-05

2.  Early ST-segment elevation acute myocardial infarction after thrombolytic therapy for acute ischemic stroke: A case report.

Authors:  Maria Mirabela Manea; Dorin Dragoş; Emanuel Stoica; Adrian Bucşa; Ioana Marinică; Sorin Tuţă
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

3.  Coronary aspiration thrombectomy after using intravenous recombinant tissue plasminogen activator in a patient with acute ischemic stroke: a case report.

Authors:  Ton Mai Duy; Phuong DaoViet; Dung Nguyen Tien; Quang-Anh Nguyen; Thien Nguyen Tat; Viet Anh Hoang; Trung Le Hong; Huy Nguyen Van; Dat Anh Nguyen; Chi Nguyen Van; Nguyen Vu Thai Lien; Vu Thi Nga; Dinh-Toi Chu
Journal:  J Int Med Res       Date:  2019-08-15       Impact factor: 1.671

4.  Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?

Authors:  Mostafa Almasi; Saeed Razmeh; Amir Hassan Habibi; Amir Hassan Rezaee
Journal:  Neurol Int       Date:  2016-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.